Volume 31, Issue 5 pp. 390-394

Primary Extracorporeal Membrane Oxygenation Versus Primary Ventricular Assist Device Implantation in Low Cardiac Output Syndrome Following Cardiac Operation

Stefan Klotz

Stefan Klotz

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
Andreas Rukosujew

Andreas Rukosujew

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
Henryk Welp

Henryk Welp

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
Christof Schmid

Christof Schmid

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
Tonny D.T. Tjan

Tonny D.T. Tjan

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
Hans H. Scheld

Hans H. Scheld

Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany

Search for more papers by this author
First published: 26 April 2007
Citations: 7
Dr. Stefan Klotz, Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Albert-Schweizer-Str. 33, 48149 Muenster, Germany. E-mail: [email protected]

Presented in part at the 14th Congress of the International Society for Rotary Blood Pumps held August 31–September 2, 2006, in Leuven, Belgium.

Abstract

Abstract: Mechanical support is often the only therapeutic option in low cardiac output (LCO) following cardiac operation using extracorporeal circulation (ECC). However, the question whether primary ventricular assist device (VAD) or primary extracorporeal membrane oxygenation (ECMO) followed by secondary VAD implantation is superior remains unclear. We analyzed the outcome of 183 patients with LCO following ECC. Primary VAD implantation (VAD) was performed on 20 patients and 163 patients underwent ECMO implantation (ECMO). Out of this group, 13 patients received a secondary VAD (ECMO-VAD). Age was significantly lower in the VAD group, while gender and type of operation were similarly distributed. Thirty-day mortalities were 50, 75, and 46% (VAD, ECMO, and ECMO-VAD, respectively; P < 0.05 ECMO vs. VAD and ECMO-VAD). Survival was best with VAD implantation 1.2 ± 1.2 days following LCO. In conclusion, the outcome of LCO following ECC remains poor. Early VAD support provides best survival. Primary or secondary VAD implantation has no impact on survival.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.